VIM and sarcomatoid carcinoma: Immunohistochemical analysis usually demonstrates a “vimentin-only” phenotype, excluding some other neoplasms such as sarcomatoid variants of squamous cell carcinoma, spindle cell carcinoma, vascular tumors, or synovial sarcoma—showing negative to their markers.